Otter Silke, Lammert Eckhard
Institute of Metabolic Physiology, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany; Institute for Beta Cell Biology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research, and German Center for Diabetes Research (DZD e.V.), Düsseldorf, Germany.
Institute of Metabolic Physiology, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany; Institute for Beta Cell Biology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research, and German Center for Diabetes Research (DZD e.V.), Düsseldorf, Germany.
Trends Endocrinol Metab. 2016 Mar;27(3):177-188. doi: 10.1016/j.tem.2015.12.004. Epub 2015 Dec 28.
Glutamate represents a key excitatory neurotransmitter in the central nervous system, and also modulates the function and viability of endocrine cells in pancreatic islets. In insulin-secreting beta cells, glutamate acts as an intracellular messenger, and its transport into secretory granules promotes glucose- and incretin-stimulated insulin secretion. Mitochondrial degradation of glutamate also contributes to insulin release when glutamate dehydrogenase is allosterically activated. It also signals extracellularly via glutamate receptors (AMPA and NMDA receptors) to modulate glucagon, insulin and somatostatin secretion, and islet cell survival. Its degradation products, GABA and γ-hydroxybutyrate, are released and also influence islet cell behavior. Thus, islet glutamate receptors, such as the NMDA receptors, might serve as possible drug targets to develop new medications for adjunct treatment of diabetes.
谷氨酸是中枢神经系统中的一种关键兴奋性神经递质,同时也调节胰岛内分泌细胞的功能和活力。在分泌胰岛素的β细胞中,谷氨酸作为一种细胞内信使,其转运至分泌颗粒可促进葡萄糖和肠促胰岛素刺激的胰岛素分泌。当谷氨酸脱氢酶被变构激活时,谷氨酸的线粒体降解也有助于胰岛素释放。它还通过谷氨酸受体(AMPA和NMDA受体)在细胞外发出信号,调节胰高血糖素、胰岛素和生长抑素的分泌以及胰岛细胞的存活。其降解产物γ-氨基丁酸和γ-羟基丁酸会被释放出来,也会影响胰岛细胞的行为。因此,胰岛谷氨酸受体,如NMDA受体,可能成为开发糖尿病辅助治疗新药物的潜在药物靶点。